Skip navigation

Refine by Type

Results 1 - 9 of 9 for CARFILZOMIB
  1. Carfilzomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) ... been treated with at least two other medications. Carfilzomib is in a class of medications called proteasome ...
  2. Myeloma (Leukemia & Lymphoma Society) - PDF  
    ... Osteonecrosis of the Jaw [ONJ] on page 25 ). Carfilzomib (Kyprolis™). This proteasome inhibitor is given intravenously (IV) ... agent lenalidomide (Revlimid) plus dexamethasone { { The proteasome inhibitor carfilzomib (Krypolis™) { { The immunomodulatory agent pomalidomide (Pomalyst®). The use ...
  3. ... such as thalidomide (Thalomid), lenalidomide (Revlimid), bortezomib (Velcade), carfilzomib (Kyprolis), and pomalidomide (Pomalyst) Corticosteroids such as prednisone ...
  4. Facts Spring 2014 (Leukemia & Lymphoma Society) - PDF  
    ... and proteasome inhibitors such as bortezomib (Velcade®) and carfilzomib (Kyprolis®). More than 50 individual drugs are used ... and the first specifically indicated to treat ALCL. Carfilzomib (Kyprolis ® ) is indicated for the treatment of patients ...
  5. ... may prevent the growth of tumors . Bortezomib and carfilzomib are proteasome inhibitors used in the treatment of ... therapy. Targeted therapy with proteasome inhibitors ( bortezomib or carfilzomib ). Chemotherapy . A clinical trial of different combinations of ...
  6. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Camptosar (Irinotecan Hydrochloride) Capecitabine CAPOX Carboplatin CARBOPLATIN-TAXOL Carfilzomib Carmubris (Carmustine) Carmustine Carmustine Implant Casodex (Bicalutamide) CeeNU ( ...
  7. Peripheral T-Cell Lymphoma (Lymphoma Research Foundation) - PDF  
    ... Campath) • Alisertib (MLN8237) • Bortezomib (Velcade) • Brentuximab Vedotin (Adcetris) • Carfilzomib (Kyprolis) • Dasatinib (Sprycel) • E7777 • Fludarabine (Fludara) • Lenalidomide (Revlimid) • ...
  8. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... dabrafenib (Tafinlar®) , pembrolizumab (Keytruda®) Multiple myeloma: Bortezomib (Velcade®) , carfilzomib (Kyprolis®) , lenaliomide (Revlimid®) , pomalidomide (Pomalyst®) Myelodysplastic/myeloproliferative disorders: ...
  9. This page lists cancer drugs approved by the Food and Drug Administration (FDA) for multiple myeloma and other plasma cell neoplasms. The list includes generic ...